Feds’ antipsychotics program fails to reduce prescriptions in assisted living
By
Alicia Lasek
Aug 23, 2022
In a federal initiative to reduce unnecessary antipsychotics prescribing, results in assisted living didn’t match the successes seen in nursing homes, a new study reveals.
Providers call for broader antipsychotic exclusions to help reduce schizophrenia diagnoses
By
Kimberly Marselas
Mar 31, 2023
Providers and quality experts are questioning why the agency hasn’t done more to review its quality measure for antipsychotic drug use.
Antipsychotic prescribing higher at nursing homes in disadvantaged areas: study
By
Kristen Fischer
Apr 25, 2024
Nursing homes in disadvantaged communities are more likely to overmedicate residents with antipsychotics, according to a study published Wednesday in JAMA Network Open.
With ‘hundreds’ of facilities audited over schizophrenia, CMS pursues harsher antipsychotics stance
By
Kimberly Marselas
Jan 19, 2024
With half of nursing homes audited in a new process admitting to misdiagnosing schizophrenia patients, the Centers for Medicare & Medicaid Services is extending its drive to reduce the use of certain drugs...
Pandemic disrupted dementia care, increased antipsychotic prescriptions: study
By
Alicia Lasek
Jan 26, 2023
Clinicians relied on these drugs to address behavioral and psychological symptoms of dementia during the pandemic. Experts are calling for a new approach to assessing treatment needs.
Ask the legal expert … about antipsychotic scrutiny
By
Norris Cunningham
Apr 10, 2023
Q: The use of antipsychotic drugs in nursing homes is already a publicly reported quality measure. Are we headed toward even more scrutiny? A: Yes, more scrutiny is coming. In February, the Department...
Antipsychotic drugs overprescribed to people with Alzheimer’s, dementia living at home
By
Kristen Fischer
Sep 07, 2023
People with Alzheimer’s disease and related dementias who receive home health are likely getting prescribed antipsychotics too often, according to a new study. The research was published Wednesday in...
CMS, OIG agree on increasing scrutiny of psychotropic drug use
By
Joe Bush
Nov 18, 2022
The Centers for Medicare & Medicaid Services will be increasing its oversight of the use of psychotropic drugs to pay closer attention to certain classes, warned the lead author of a federal report identifying...
U.S. hospices lack standard for benzodiazepines, antipsychotics use: study
By
Alicia Lasek
Mar 28, 2023
Investigators have found significant variation in what is considered clinically appropriate use of these drugs for the U.S. hospice population.
Use of common hospice drugs varies widely by state, highlighting limited guidance
By
Alicia Lasek
Aug 16, 2022
Antipsychotics prescribing rates, for example, ranged from 62% for hospice beneficiaries in Oregon to 15% in Oklahoma, investigators say. Five states topped the prescriptions list.